REMMA Bellvitge: the new research program that brings together professionals from the Bellvitge Health Campus who work on adult rare diseases
AECC will fund innovative strategies to improve the treatment of childhood cancer and overcome resistance in prostate cancer
The AECC allocates more than 900,000 euros to oncological research at IDIBELL Read More »
The Acción Estratégica en Salud (AES) of the Carlos III Health Institute (ISCIII) reaffirms, once again, as the main engine for biomedical and health research of excellence in Spain. Through these annual competitive grants, the ISCIII not only finances innovative and high-quality biomedical research projects, but also bets on strengthening the scientific fabric and developing
Researchers from IDIBELL and UB has identified two regions within the Vaccinia virus genome, where there would be enough space to introduce several genetic sequences in a stable way
A macro research confirms the genetic relationship between 14 different psychiatric disorders and groups them into five new families.
A study with the participation of Bellvitge Campus proposes a new strategy to act directly in the place where the tumor has been extracted: a patch that sticks to the brain tissue and traps the residual tumor cells
A patch inspired by mussels could help reduce relapse of the most aggressive brain tumor Read More »
A study by Bellvitge Hospital and IDIBELL describes a new genetic variant of a type of minority epilepsy
Six active researchers from IDIBELL will engage in a dialectical duel at the 9th sLHam of Women Scientists
Research that changes the world from Bellvitge and at the hand of women scientists Read More »
The joint contribution will allow progress in a line of research that focuses on immunotherapy
